Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

A possible drug interaction between rifampicin and enalapril

Summary

When a 35-year-old man with essential hypertension was treated with antibiotics for brucellosis his blood pressure rose significantly. While all other treatment was kept constant rifampicin was discontinued. On rechallenge rifampicin did not alter serum concentrations of enalapril or the area under the curve (AUC) between 0 and 7 h, but it did reduce the AUC of the active metabolite enalaprilat by 31%. These observations suggest that there may be an interaction between rifampicin and enalapril, causing reduced hypotensive efficacy of enalapril. The mechanism of such an interaction merits further study, but it could be due to enhanced renal clearance of enalaprilat.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Hichens M, Hand EL, Mulcahy WS (1981) Radioimmunoassay for angiotensin converting enzyme inhibitors. Ligand Q 4: 43

  2. 2.

    Ohnhaus EE, Kirchhof B, Peheim E (1979) Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital and rifampicin. Clin Pharmacol Ther 25: 591–597

  3. 3.

    Ulm EH (1983) Enalapril maleate (MK-421), a potent nonsulphhydryl angiotensin-converting enzyme inhibitor: absorption, disposition and metabolism in man. Drug Metab Rev 14: 99–110

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kandiah, D., Penny, W.J., Fraser, A.G. et al. A possible drug interaction between rifampicin and enalapril. Eur J Clin Pharmacol 35, 431–432 (1988). https://doi.org/10.1007/BF00561378

Download citation

Key words

  • rifampicin
  • enalapril
  • hypertension
  • drug interaction
  • case report